Page 119 - Small Animal Internal Medicine, 6th Edition
P. 119

CHAPTER 4   Cardiac Arrhythmias and Antiarrhythmic Therapy   91



                   TABLE 4.2
  VetBooks.ir  Dosage of Antiarrhythmic Drugs—cont’d

             AGENT
                             DOSAGE
             Class IV
             Diltiazem       Dog: Acute IV for rapid rate control of AF: 0.05-0.10 mg/kg IV over 2-5 minutes, can repeat if needed.
                             Acute IV for SVT: 0.1-(0.2) mg/kg over 2-5 minutes IV, can repeat to cumulative IV dose of
                               0.3-0.4 mg/kg; monitor blood pressure. CRI (if frequent SVT recurrence): 0.002-0.006 mg/kg/min
                               (or 0.12-0.35 mg/kg/h)
                             PO loading dose: 0.5 mg/kg PO followed by 0.25 mg/kg PO q1h to a total of 1.5(-2.0) mg/kg or
                               conversion
                             Oral maintenance: initial dose 0.5-1 mg/kg (up to 2-3 mg/kg) PO q8h
                             Extended release (diltiazem ER): 1-4 (up to 6) mg/kg PO q12h
                             Cat: Same?; Or 1.5-2.5 mg/kg (or 7.5-10 mg/cat) PO q8h; sustained-release preparations: diltiazem
                               ER, 30 mg/cat/day (one half of a 60 mg controlled-release tablet within the 240-mg gelatin
                               capsule), can increase to 60 mg/day in some cats if necessary
                             Cardizem-CD, 10 mg/kg/day (45 mg/cat ≅ 105 mg of Cardizem-CD ≅ amount that fits into small end
                               of No. 4 gelatin capsule)
             Verapamil       Dog: initial dose, 0.02-0.05 mg/kg slowly IV, can repeat q5min up to a total of 0.15(-0.2) mg/kg;
                               0.5-2 mg/kg PO q8h. (Note: diltiazem preferred instead)
                             Cat: initial dose, 0.025 mg/kg slowly IV, can repeat q5min up to a total of 0.15(-0.2) mg/kg;
                               0.5-1 mg/kg PO q8h. (Note: diltiazem preferred instead)
             Anticholinergic
             Atropine        Dog: 0.02-0.04 mg/kg IV, IM, SC; 0.04 mg/kg PO q6-8h
                             Cat: same
                             Atropine challenge test: 0.04 mg/kg IV (see text, p. 97)
             Glycopyrrolate  Dog: 0.005-0.01 mg/kg, IV or IM; 0.01-0.02 mg/kg SC
                             Cat: same
             Propantheline   Dog: 0.25-0.5 mg/kg or 3.73-7.5 (-15) mg/dog PO q8-12h
                             Cat: —
             Hyoscyamine     Dog: 0.003-0.006 mg/kg PO q8h
                             Cat: —
             Sympathomimetic
             Isoproterenol   Dog: 0.04-0.08 mcg/kg/min CRI
                             Cat: same
             Theophylline    Dog: 10 mg/kg PO q12h
               (extended rel.)  Cat: 10-15 mg/kg q24h
             Terbutaline     Dog: 0.14 mg/kg, or 2.5-5 mg/dog, PO q8-12h
                             Cat: 0.1-0.2 mg/kg, or 0.625-1.25 mg/cat, PO q12h
             Other Agents
             Digoxin         See Table 3.3 for PO dosing; see Box 3.1 and p. 85 for IV
             Edrophonium     Dog: 0.05-0.1 mg/kg IV (have atropine and endotracheal tube available)
                             Cat: same?
             Phenylephrine   Dog: 0.004-0.01 mg/kg IV
                             Cat: same?

            CRI, Constant-rate infusion; —, effective dosage not known.


            slow the drug’s metabolism. Drugs that decrease liver blood   Procainamide
            flow (such as propranolol, cimetidine, and chloramphenicol)   Procainamide HCl has electrophysiologic effects similar to
            also slow lidocaine’s metabolism and predispose to toxicity.   those of quinidine. These include both direct and indirect
            Animals with heart failure could have reduced hepatic blood   (vagolytic) effects. Procainamide is indicated for the treat-
            flow and so might require a lower dosage of the drug.  ment  of premature  ventricular  (and sometimes  atrial)
   114   115   116   117   118   119   120   121   122   123   124